Cerebrospinal fluid (CSF) concentrations of RTN4 (Nogo) were found to be significantly elevated in patients with AD, PD, and MS compared to controls, highlighting a connection between neurodegeneration and an endogenous RhoA activator [107]. The gene discussed is RHOA; the disease is Parkinson disease.